Patents by Inventor Isu Hong

Isu Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of age-related macular degeneration using RNA complexes that target MyD88 or TLR3
    Patent number: 10590423
    Abstract: In certain aspects, provided herein are RNA complexes that inhibit Myeloid differentiation primary response gene 88 (MyD88) and/or Toll-like receptor 3 (TLR3) and are useful in the treatment of age-related macular degeneration (AMD). In certain aspects, provided herein are pharmaceutical compositions comprising such RNA complexes and methods of using such RNA complexes and pharmaceutical compositions.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: March 17, 2020
    Assignee: OliX Pharmaceuticals, Inc.
    Inventors: Dong-ki Lee, Sun Woo Hong, Isu Hong, Jihye Hwang
  • RNA complexes that inhibit melanin production
    Patent number: 10512600
    Abstract: In certain aspects, provided herein are RNA complexes (e.g., asymmetric RNA complexes, such as asiRNAs and lasiRNAs) that inhibit tyrosinase expression and are therefore useful for reducing melanin production and for treating pigmentation-related disorders associated with excessive melanin production, such as melasma and age spots.
    Type: Grant
    Filed: August 13, 2018
    Date of Patent: December 24, 2019
    Assignee: OliX Pharmaceuticals, Inc.
    Inventors: Sun Woo Hong, Isu Hong, Ji Hyun Kim
  • RNA COMPLEXES THAT INHIBIT MELANIN PRODUCTION
    Publication number: 20190038538
    Abstract: In certain aspects, provided herein are RNA complexes (e.g., asymmetric RNA complexes, such as asiRNAs and lasiRNAs) that inhibit tyrosinase expression and are therefore useful for reducing melanin production and for treating pigmentation-related disorders associated with excessive melanin production, such as melasma and age spots.
    Type: Application
    Filed: August 13, 2018
    Publication date: February 7, 2019
    Inventors: Sun Woo Hong, Isu Hong, Ji Hyun Kim
  • TREATMENT OF AGE-RELATED MACULAR DEGENERATION USING RNA COMPLEXES THAT TARGET MYD88 OR TLR3
    Publication number: 20180327755
    Abstract: In certain aspects, provided herein are RNA complexes that inhibit Myeloid differentiation primary response gene 88 (MyD88) and/or Toll-like receptor 3 (TLR3) and are useful in the treatment of age-related macular degeneration (AMD). In certain aspects, provided herein are pharmaceutical compositions comprising such RNA complexes and methods of using such RNA complexes and pharmaceutical compositions.
    Type: Application
    Filed: July 23, 2018
    Publication date: November 15, 2018
    Inventors: Dong-ki Lee, Sun Woo Hong, Isu Hong, Jihye Hwang
  • RNA complexes that inhibit melanin production
    Patent number: 10064801
    Abstract: In certain aspects, provided herein are RNA complexes (e.g., asymmetric RNA complexes, such as asiRNAs and lasiRNAs) that inhibit tyrosinase expression and are therefore useful for reducing melanin production and for treating pigmentation-related disorders associated with excessive melanin production, such as melasma and age spots.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: September 4, 2018
    Assignee: OliX Pharmaceuticals, Inc.
    Inventors: Sun Woo Hong, Isu Hong, Ji Hyun Kim
  • Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
    Patent number: 10059949
    Abstract: In certain aspects, provided herein are RNA complexes that inhibit Myeloid differentiation primary response gene 88 (MyD88) and/or Toll-like receptor 3 (TLR3) and are useful in the treatment of age-related macular degeneration (AMD). In certain aspects, provided herein are pharmaceutical compositions comprising such RNA complexes and methods of using such RNA complexes and pharmaceutical compositions.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: August 28, 2018
    Assignee: OliX Pharmaceuticals, Inc.
    Inventors: Dong Ki Lee, Sun Woo Hong, Isu Hong, Jihye Hwang
  • TREATMENT OF AGE-RELATED MACULAR DEGENERATION USING RNA COMPLEXES THAT TARGET MYD88 OR TLR3
    Publication number: 20170137828
    Abstract: In certain aspects, provided herein are RNA complexes that inhibit Myeloid differentiation primary response gene 88 (MyD88) and/or Toll-like receptor 3 (TLR3) and are useful in the treatment of age-related macular degeneration (AMD). In certain aspects, provided herein are pharmaceutical compositions comprising such RNA complexes and methods of using such RNA complexes and pharmaceutical compositions.
    Type: Application
    Filed: November 15, 2016
    Publication date: May 18, 2017
    Inventors: Dong Ki Lee, Sun Woo Hong, Isu Hong, Jihye Hwang
  • RNA COMPLEXES THAT INHIBIT MELANIN PRODUCTION
    Publication number: 20170027837
    Abstract: In certain aspects, provided herein are RNA complexes (e.g., asymmetric RNA complexes, such as asiRNAs and lasiRNAs) that inhibit tyrosinase expression and are therefore useful for reducing melanin production and for treating pigmentation-related disorders associated with excessive melanin production, such as melasma and age spots.
    Type: Application
    Filed: July 27, 2016
    Publication date: February 2, 2017
    Inventors: Sun Woo Hong, Isu Hong, Ji Hyun Kim